[go: up one dir, main page]

AU1493401A - Treatment of carbon monoxide poisoning - Google Patents

Treatment of carbon monoxide poisoning

Info

Publication number
AU1493401A
AU1493401A AU14934/01A AU1493401A AU1493401A AU 1493401 A AU1493401 A AU 1493401A AU 14934/01 A AU14934/01 A AU 14934/01A AU 1493401 A AU1493401 A AU 1493401A AU 1493401 A AU1493401 A AU 1493401A
Authority
AU
Australia
Prior art keywords
treatment
carbon monoxide
monoxide poisoning
poisoning
carbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14934/01A
Inventor
Benjamin P. Gilmer
Christian Tomaszewski
John A. Watts Jr.
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Charlotte Mecklenburg Hospital
Original Assignee
Charlotte Mecklenburg Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Charlotte Mecklenburg Hospital filed Critical Charlotte Mecklenburg Hospital
Publication of AU1493401A publication Critical patent/AU1493401A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A61K31/10—Sulfides; Sulfoxides; Sulfones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU14934/01A 1999-09-30 2000-09-28 Treatment of carbon monoxide poisoning Abandoned AU1493401A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15719899P 1999-09-30 1999-09-30
US60/157198 1999-09-30
PCT/US2000/041016 WO2001022960A1 (en) 1999-09-30 2000-09-28 Treatment of carbon monoxide poisoning

Publications (1)

Publication Number Publication Date
AU1493401A true AU1493401A (en) 2001-04-30

Family

ID=22562728

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14934/01A Abandoned AU1493401A (en) 1999-09-30 2000-09-28 Treatment of carbon monoxide poisoning

Country Status (2)

Country Link
AU (1) AU1493401A (en)
WO (1) WO2001022960A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7968124B2 (en) * 2004-07-13 2011-06-28 Lyotropic Therapeutics, Inc. Compositions for the reversal and detoxification of anesthetics and other compounds and methods of their use
AU2007351338B2 (en) * 2006-12-07 2013-04-04 Lyotropic Therapeutics, Inc. Compositions for the reversal and detoxification of anesthetics and other compounds and methods of their use
BRPI0806371A2 (en) 2007-01-22 2011-09-13 Gtx Inc nuclear receptor binding agents
US9623021B2 (en) 2007-01-22 2017-04-18 Gtx, Inc. Nuclear receptor binding agents
US9604931B2 (en) 2007-01-22 2017-03-28 Gtx, Inc. Nuclear receptor binding agents
AU2015264362B2 (en) * 2014-05-22 2020-05-07 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Use of microperoxidases for the treatment of carboxyhemoglobinemia
CN104814952B (en) * 2015-04-16 2017-12-26 嘉兴学院 A kind of method for promoting carbon monoxide emitter release carbon monoxide and preventing from being formed precipitation
RU2723165C9 (en) * 2019-05-20 2020-09-03 Александра Викторовна Савченко Method for reducing the severity of the long-term effects of carbon monoxide poisoning

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5496836A (en) * 1994-05-05 1996-03-05 Mount Sinai School Of Medicine Of The City University Of New York Use of famotidine and related compounds in the treatment of movement disorders

Also Published As

Publication number Publication date
WO2001022960A1 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
AU5639900A (en) Shaped scalpel
AU3570799A (en) Titanium-containing catalyst composition and processes therefor and therewith
AU2070801A (en) Improved photoplethysmographic instrument
AUPP607198A0 (en) Process and catalysts for the methanation of oxides of carbon
AU4490300A (en) Catalytic converter arrangement
AU4281300A (en) Treatment of carbon monoxide poisoning
AU5013100A (en) Maize rs81 promoter and methods of use thereof
AU4063400A (en) Catalytic trap and methods of making and using the same
AU5730199A (en) Catalyst and process for the oxidation of methane to methanol
AU6908500A (en) Treatment for narcolepsy
AU5724000A (en) Anastomosis system and methods for use
AU3791601A (en) Treatment of coal
AU2644497A (en) Biosensors
AU2002219229A1 (en) Means for the diagnosis and therapy of CTCL
AU5547000A (en) Novel treatment
AU5840200A (en) Treatment of diabetes and related pathologies
AU5752698A (en) Enzymatic oxidation process
AU4129297A (en) Carbon monoxide removal
HUP0203138A3 (en) Carbon monoxide source for preparation of transition-metal-carbonyl-complexes
AU2001230356A1 (en) Carbon monoxide detector
AU1493401A (en) Treatment of carbon monoxide poisoning
AU4953299A (en) Analytic stethoscope
AU4625100A (en) Stable catalysts and processes for making and using the same
AUPP810399A0 (en) Catalytic molecules
AU4556800A (en) Novel treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase